H.I.G. BioHealth Partners

H.I.G. BioHealth Partners

15 Mar 2017

SEC FORM D

sec
+4
03 Jan 2017
$7,100,000
Venture capital (Series B)

Intact Vascular Closes on Additional Series B Funding to Advance Development of the Tack Endovascular System® for Peripheral Artery Disease Treatment | Business Wire

businesswire
+2
18 Aug 2016
$30,000,000
Venture capital (Series D)

Nutrinia Announces $30 Million Series D Financing to Fund Clinical Development of Lead Product | Business Wire

businesswire
+3
09 Aug 2016

Iconic Therapeutics Closes $10M Series C Financing

FinSMEs
+1